Why is Scilex Holding Co. ?
- Poor long term growth as Operating profit has grown by an annual rate -502.16% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -39.48
- NET SALES(HY) At USD 20.46 MM has Grown at -33.6%
- INTEREST(HY) At USD 5.48 MM has Grown at 377.77%
- NET PROFIT(Q) Lowest at USD -188.73 MM
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -25.03%, its profits have fallen by -270.4%
- Along with generating -25.03% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Scilex Holding Co. for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD 24.1 MM
Highest at 9.59 times
At USD 20.46 MM has Grown at -33.6%
At USD 5.48 MM has Grown at 377.77%
Lowest at USD -188.73 MM
Grown by 12.33% (YoY
Lowest at 1.85 times
Lowest at USD -185.49 MM
Lowest at -1,756.53 %
Lowest at USD -189.31 MM
Lowest at USD -22.17
Here's what is working for Scilex Holding Co.
Operating Cash Flows (USD MM)
Inventory Turnover Ratio
Depreciation (USD MM)
Here's what is not working for Scilex Holding Co.
Net Sales (USD MM)
Interest Paid (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Net Profit (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
EPS (USD)
Debtors Turnover Ratio
Raw Material Cost as a percentage of Sales






